Secondary and exploratory outcomes included changes in waist circumference, body composition, and glycated hemoglobin (HbA1c), a validated marker of long-term glycemic control
Retatrutide is studied in controlled laboratory models involving multi-receptor incretin biology and metabolic pathway regulation
A two-hormone drug, GLP-1 plus glucagon, that Innovent licensed from Eli Lilly for China and took all the way through development
This posed a particular challenge to Novo Nordisks sales of its weight loss therapeutics, as did competition from Eli Lillys Zepbound, a glucose-dependent insulinotropic polypeptide and GLP-1 receptor, which performed better than Wegovy in terms of its ability to lower weight
The Dangers of Sarcopenia Sarcopenia can lead to a decreased ability to perform daily activities, making it more difficult to maintain independence and quality of life